No relief for diabetics as inflation act becomes law
Reuters, 16 Aug 2022
A cap on the price of the diabetes medication insulin at $35 per month for people with private medical insurance remains elusive even in a new sweeping budget package meant to bring financial relief to Americans.
Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.
Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en